FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
about
Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway.Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers.Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling.Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor.Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer.Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.Adenocarcinomas on the rise--does it influence survival from oesophageal cancer?miR-204 reverses temozolomide resistance and inhibits cancer initiating cells phenotypes by degrading FAP-α in glioblastoma.Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway
P2860
Q33555573-5509A474-59C8-4669-B475-617E43C19BDBQ33773960-980F4877-E71B-40DF-82C3-A927953A1151Q33942225-AAAEC16A-B0BD-43B0-B24A-A2065D19C29EQ34075875-7D88DA30-1FC7-44C7-8EFE-684133970D19Q35182174-B0ABA19D-A3D4-477A-9724-6715994ECFC7Q35776154-C7A8A902-9E76-4456-B66D-5B2E1E3B0D1EQ37413637-AACD0D6F-E421-49AF-94EC-8447350DA264Q37452281-011F938C-018A-48C0-8B04-B89B03821019Q37552929-D5A7E522-CF75-49E4-A967-F7FA37F692ABQ37801943-F27E7E02-7124-4FD6-8FE1-C5224B700A8BQ37809871-002CD099-6E75-48C0-98D3-FCCDE64BE130Q38833520-F429B5F2-C305-49AE-868C-A49A4DD70466Q39144346-360002F3-D553-419C-8140-9274F585C038Q46622510-BFEA8B5E-FC97-438D-9EBC-D5255A6979F8Q54090233-76E19DC6-A4B4-4E7B-AF01-51D8E5DD419BQ59127385-EDC80C0B-578F-4E22-A8E8-B4B98B2063E7
P2860
FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
FAP-alpha and uPA show differe ...... malignant esophageal lesions.
@en
FAP-alpha and uPA show differe ...... malignant esophageal lesions.
@nl
type
label
FAP-alpha and uPA show differe ...... malignant esophageal lesions.
@en
FAP-alpha and uPA show differe ...... malignant esophageal lesions.
@nl
prefLabel
FAP-alpha and uPA show differe ...... malignant esophageal lesions.
@en
FAP-alpha and uPA show differe ...... malignant esophageal lesions.
@nl
P2093
P2860
P1476
FAP-alpha and uPA show differe ...... malignant esophageal lesions.
@en
P2093
Jahn Marthin Nesland
Karl-Erik Giercksky
Ljiljana Vlatkovic
Mariusz Adam Goscinski
Vivi Ann Flørenes
Zhenhe Suo
P2860
P356
10.1080/01913120802034934
P577
2008-05-01T00:00:00Z